Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 1mg; 500mg - rosiglitazone (rosiglitazone maleate) 1mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 500mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 500mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 1000mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 1000mg - biguanides

Canada - English - Health Canada

pharmascience inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 4mg; 1000mg - rosiglitazone (rosiglitazone maleate) 4mg; metformin hydrochloride 1000mg - biguanides

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 500mg; 50mg - metformin hydrochloride 500mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 850mg; 50mg - metformin hydrochloride 850mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

Canada - English - Health Canada

apotex inc - metformin hydrochloride; sitagliptin (sitagliptin phosphate monohydrate) - tablet - 1000mg; 50mg - metformin hydrochloride 1000mg; sitagliptin (sitagliptin phosphate monohydrate) 50mg

European Union - English - EMA (European Medicines Agency)

smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).

Canada - English - Health Canada

apotex inc - sitagliptin (sitagliptin phosphate monohydrate); metformin hydrochloride - tablet (extended-release) - 50mg; 500mg - sitagliptin (sitagliptin phosphate monohydrate) 50mg; metformin hydrochloride 500mg